Systematically Testing the Evidence on Marijuana

Cannabinoid CBG reduces anxiety and stress in first human clinical trial

Source: WSU Insider

Sep 27, 2024 | Emerging Products, Research

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It may even have some memory enhancing effects, according to a new study in Scientific Reports.  See the WSU Insider article here.

Archives

Click here to learn how STEM selects new articles.